FDA warns against Coldrif syrup batch after MP child deaths

Hero Image
Newspoint
Panaji: The food and drugs administration (FDA) on Monday issued instructions to the public to stop using Coldrif syrup , batch no SR-13, after the deaths of children in Madhya Pradesh .

“The public is urged to exercise caution to prevent any further risk to life,” the FDA said.

The FDA has also instructed all pharmacies and distributors to stop the sale and distribution of Coldrif syrup, batch no SR-13. If this batch is available, it must be reported to the directorate by pharmacies via email off-dfa.goa@nic.in and the public.

The office of the controller, food and drugs administration, Madhya Pradesh, in a letter dated Oct 4, informed the FDA about the children’s deaths in MP and that they drew a sample of Coldrif syrup (paracetamol, phenylephrine hydrochloride, chlorpheniramine maleate syrup), batch no SR-13, manufactured in May 2025 and expiring in April 2027. This syrup, manufactured by M/s Sresan Pharmaceutical, Manufacturer No. 787, Bangalore Highways, Sunguvarchathram (Mathura), Kancheepuram district, Tamil Nadu, was allegedly found to be adulterated with diethylene glycol (DEG) (46.28% w/v), a toxic substance.